Johnson & Johnson’s recent FDA approval for a drug-eluting contact lens has changed the game for contact lens wearers suffering from allergic eye itch. Now, medtech analysts at Needham & Co. have issued a report in which they take a closer look at both the contact lens and intraocular lens markets, noting how both are poised for growth. The analysts believe that a mix shift toward premium contact lenses will serve as a durable growth driver for the roughly $9B contact lens market. They also expect premium lenses in cataract surgeries to drive growth in the intraocular lens (IOL) market. The analysts estimate the IOL market is currently valued at about $3B.

Categorized in: